Summary: Cell viability and number of granulocyte-monocyte colony forming units (CFU-GM) were systematically assessed in 57 patients who had undergone transplantation of the autologous bone marrow for treatment of haematologic malignancies. Bone marrow cell cultivation in agarose with feeder layers appeared inferior to that performed in agarose with recombinant human granulocyte-monocyte colony stimulating factor and methylcellulose with phytohaemaglutinin leukocyte-conditioned medium. Since the transplant cells were frozen in liquid nitrogen between harvesting and reinfusion, the following samples were tested: buffy coat cells, buffy coat cells immediately after addition of dimethylsulphoxide, cell sample that had been frozen for 24 hours, and frozen transplant cells at the time of thawing and transplantation. Each procedural step decreased both cell viability and the number of CFU-GM, but since the lymphohaematologic recovery in all patients followed the pattern reported in the literature for high-quality transplants, we concluded that our transplants retained the necessary number of progenitor cells. It appears that the best strategy for dynamic assessment of the transplant quality would be to perform tests after every step of the transplant processing. Cell viability and number of progenitors per body weight in transplants were also found to be associated with probability of neutrophil reconstitution after bone marrow reinfusion.
Introduction
the numbers of lymphocytes and platelets (1, 7) in the Autologous bone marrow transplantation is a modern Post-transplantation time period, and powerful method for treatment of haematological Since there is still no wor ldwide standardized in vitro and non-haematological malignancies (1) . However, the technique for CFU-GM cultivation, the choice of methods for bone marrow harvesting, freezing and stor-met hod depends on laboratory practice, i.e. available ing (2, 3) , as well as laboratory methods for assessing technologies, reproducibility and training. It has been the number of granulocyte-monocyte/macrophage col, suggested that eac h routine clinical laboratory should ony forming units (CFU-GM) in the transplants (4) vary have its own standard (8)t substantially in different transplantation centres. Although the pluripotent stem cell is responsible for lym-The aim of this investigation was an evaluation of the phohaematopoietic recovery of a patient, the committed CFU-GM content and cell viability characteristics of progenitor cell grown in vitro (CPU) is strongly related bone marrow transplants during their preparation for to the posttransplantation recovery of blood cell popula-transplantation. Since 1988, our team has performed a tions (2) and is thus used for estimation of the transplant number of autologous bone marrow transplantations (9) , quality. Its content in the transplant mostly affects the and the resulting data has enabled us to define the most numbers of leukocytes and neutrophils (5, 6), but also rational scheme for the procedure and our respective lab-oratory standards. The results of our investigation were improved by relating the laboratory test results of the bone marrow transplants to the posttransplantation haematological recovery of neutrophils in peripheral blood of the patients.
Patients and Methods

Patients
The study was performed on 57 bone marrow samples from patients undergoing autologous transplantation in the period from March 1988 to July 1993. . The first two protocols were used for all malignancies, and the third one for lymphomas only.
Methods
Buffy coat was prepared from bone marrow on a COBE 2991 Blood Cell Processor, chilled on ice to 4 °C, mixed with dimethylsulphoxide (volume fraction 0.1) as cryoprotective agent at the same temperature, frozen using a controlled freezing system and stored in liquid nitrogen at -196°C. Cell viability and clonogeneic activity were tested in three preparation steps before transplant reinfusion (buffy coat, buffy coat immediately after addition of dimethylsulphoxide, and buffy coat plus dimethylsulphoxide 24 hours after freezing), and in a transplant sample at the time of reinfusion.
Mononuclear cells were prepared from the bufify coat by gradient separation (1.077 kg/1) and washed twice in RPMI-1640 medium (Immunology Institute, Zagreb, Croatia). Samples with dimethylsulphoxide were slowly diluted immediately after thawing 1:10 with medium containing 0.01 volume fraction of L-glutamine (Lglutamine 200 mmol/1, Gibco, Paisley, UK) and 0.1 volume fraction of fetal calf serum (Gibco). Cell viability was tested by the trypan blue exclusion method (Trypan blue 0.4%, Sigma, USA). Clonogeneic activity was assessed using three methods. For 33 samples, 10 5 mononuclear cells were mixed with medium containing fetal calf serum and agar (final volume fractions 0.1 and 0.03, respectively) in a volume of 1 ml, then layered over a 5 to 10 day-old feeder layer prepared from healthy donor leukocytes (10) . Cultivation on feeder layers was always done in parallel with a control sample containing a known number of progenitors; if the number of CFU-GM in the control was 10% less or greater than expected, the feeder layer was replaced with a new one. For 9 samples, 10 5 mononuclear cells were resuspended in medium containing the same quantities of fetal calf serum and agar, arid 250 ng of recombinant human granulocyte-monocyte colony stimulating factor (GM-CSF) in 1 ml final volume (GMC 89-107, Sandoz Pharma AG, Basel, Switzerland). For the remaining 15 samples, 5 Χ 10 4 mononuclear cells were mixed with 0.5 ml of commercially prepared medium (MethoCult H4432, StemCell Technologies Inc, Vancouver, Canada) containing methylcellulose, phytohaemagglutinin leukocyte-conditioned medium (volume fraction 0.1) and 3 X 10 3 U/l of recombinant human erythropoietin (11) .
For all methods, plating was done in triplicate and the average number of CFU-GM was calculated.
Data analysis
All the data are numerical. They are presented with the median value, and the 10th to 90th percentile range, because all values except cell viability were not normally distributed. The differences between groups were tested using the Wilcoxon test for matched pairs and Kruskal-Wallis non-parametric analysis for several group means.
The probable time of haematopoietic engraftment was taken as the posttransplantation day on which the neutrophil counts in the peripheral blood reached values of 0.2 X 10 5 /1 and 0.5 X 10 5 /1 respectively, as calculated and constructed by the Kaplan-Meier method of incomplete observation. Patients were censored if they did not attain the count by the last day of the follow up. The influence of various laboratory conditions on the engraftment kinetics was assessed by using Cox's forward stepwise multivariate regression analysis. TTie following variables were analysed: transplant volume, total number of mononuclear cells, number of mononuclear cells per transplant volume and per body weight, cell viability, total number of CFU-GM, and number of CFU-GM per 10 5 mononuclear cells and per body weight. All reported p-values referred to two-sided tests, and were considered significant if less then 0.05.
Results
For each transplant, samples in four different steps of preparation were analysed: buffy coat cells after ficoll separation, buffy coat cells immediately after addition of dimethylsulphoxide, the cells that had been frozen at least 24 hours, and the cells from the frozen transplant at the day of transplantation. Average cell viability and number of CFU-GM in the samples are presented in table 1. After each procedural step, the viability of cells was significantly lower, except between the first two samples (buffy coat and buffy coat with dimethylsulphoxide). Similarly, the number of the CFU-GM was significantly lower after each procedural step except for the difference between samples with dimethylsulphoxide before and 24 h after freezing (tab. 1, ρ < 0.05). Table 2 presents the number of CFU-GM according to laboratory method used for stimulation of the growth of bone marrow cells in the culture: feeder layers, agarose with recombinant human GM-CSF, methylcellulose with phytohaemagglutinin leukocyte-conditioned medium. There was no significant difference in CFU-GM content in relation to the cultivation method, although, compared with the other two techniques, values obtained with cells from the fresh buffy coat were considerably lower if feeder layer was used (tab. 2,40 compared with 50 and 51 CFU-GM per 10 5 mononuclear cells). In general, however, the data showed the same pattern of decreasing CFU-GM values as described in table 1, i.e. lower numbers of the CFU-GM after each step of the processing of the transplant.
We also investigated CFU-GM content according to the type of malignancy and therapy,*as reported in the Pa- p-values represent probabilities derived from testing the differences ods using non-parametric analysis of variance, of CFU-GM numbers between all three different cultivation methtients section, but there was no significant difference bet ween respective patient groups (data not shown).
In patients presented in this study ( fig. 1 ), a neutrophil count in the peripheral blood of 0.2 X 10 5 /1 was attained between 7 and 58 days after transplantation (median 14 days, two patients died before achieving the count), and of 0.5 X 10 5 /1 between 11 and 72 days after transplantation (median 22 days, three patients died before achieving the count). Table 3 presents laboratory values analysed for their influence on the engraftment kinetics of neutrophil cells in peripheral blood of the patients. Only cell viability and number of granulocyte-monocyte progenitors per kg of body weight were found to be independently and significantly associated with the probability of haematopoietic reconstitution, both determined on the basis of neutrophil concentrations, and with negative correlation coefficients.
Discussion
Cell viability and number of CFU-GM, together with the total number of mononuclear cells in a bone marrow transplant, are basic indicators of the quality of a transplant, especially if freezing of autologous bone marrow is utilized. The quality of the sample must always be verified before transplantation, because cryoprotective agents, such as dimethylsulphoxide, and cooling and storing techniques can irreparably damage the cells (12) . Procedure-related and method-related decreases in cell viability and progenitor content are expected, but the minimal transplant quality, which will allow a good and fast posttransplantation haematologic recovery, must be both monitored and achieved ( fig. 1 ). Inasmuch as all our patients recovered haematologically within the time period reported as clinically favorable (1, 5, 13, 14) , our transplant procedure can be considered as serviceable. Multivariate analysis reported in table 3 revealed that the only significant laboratory factors influencing the delay of neutrophil recovery (presented in fig. 1 ) are cell viability and progenitor content related to the body weight. This is in accord with some studies (2, 5, 6) , while others have failed to confirm it (15) . Only the recovery of neutrophils was studied because these cells mature and differentiate directly from CFU-GM progenitors. Low correlation coefficients (table 3) suggest that some other conditions, different from those investigated, were also associated with neutrophil engraftment, and that viability and CFU-GM number cannot be used directly for predicting the day of attaining the desired concentration. However, prediction of posttransplantation recovery was not the aim of the study. We simply wanted to assess the need for a valuable laboratory technique for testing the validity of the transplant preparation procedure.
Viability and CFU-GM values shown in tables 1 and 2 are actually used as our laboratory standards of the autologous bone marrow transplant quality. It should also be noted that they do not represent minimal, optimal or maximal values, but rather the values clinically related to good haematologic recovery. Our sub- Although the data did not prove statistically significant, cell cultivation using recombinant human GM-CSF and phytohaemagglutinin leukocyte-conditioned medium in methylcellulose as stimulating factors yielded results that appeared much better than those obtained with feeder layers (tab. 2). The differences were so impressive (tab. 2) that we believe that feeder layers should be avoided if possible, at least for routine laboratory testing. The facility of operation and accuracy of results using completely prepared and standardized media, such as that with phytohaemagglutinin leukocyte-conditioned medium in methylcellulose, support their use over any other technique in the routine laboratory procedures. In addition, the general adoption of such media would permit direct comparison of data from different laboratories, which in turn would allow the introduction of multicentre evaluations.
Some centres for monitoring transplant quality use methods for CFU-GM cultivation before freezing, some after freezing and some before and after as a standard (2) . We feel that the best strategy of a dynamic assessment of the transplant quality would be to perform standardized tests after every step, using any chemical or physical procedure, i. e. in fresh samples before and after adding cryoprotective agent, in the sample stored in liquid nitrogen, and finally in a transplant sample at the time of reinfusion. With this type of laboratory routine, any patient can be individually evaluated (values after the procedure related to values before the procedure), as well being compared with any other patient analysed for cell progenitor content and cell viability in the same or any other clinical laboratory.
